Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,624 across all filing types
Latest filing 2025-05-26 Proxy Solicitation & In…
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
PROXY FORM FOR USE AT THE 2024 ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 91% confidence The document is a proxy form for use at the 2024 Annual General Meeting, providing voting instructions, resolutions to be passed, and proxy appointment details. This is part of materials sent to shareholders to request votes for the meeting, which matches the definition of a Proxy Solicitation & Information Statement.
2025-05-26 English
NOTICE OF 2024 ANNUAL GENERAL MEETING
AGM Information Classification · 85% confidence The document is a formal notice of the company’s 2024 Annual General Meeting, specifying date, venue, resolutions to be tabled, proxy appointment instructions, and procedural notes under Hong Kong Exchange rules. It is not the full annual report, financial statements, or results announcement, nor is it the post‐meeting materials. Therefore, it is classified as AGM Information (AGM-R).
2025-05-26 English
2024 ANNUAL GENERAL MEETING CIRCULAR
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a comprehensive shareholder circular issued in advance of the 2024 Annual General Meeting (AGM) and related class meetings, containing the notice of meeting, full agenda of resolutions (including board reports, financial accounts report, profit distribution plan, re-appointment of auditors, director remuneration, amendments to articles and procedures), proxy forms and explanatory appendices. This type of filing is not the Annual Report itself but rather the solicitation of proxies and information provided to shareholders to enable informed voting at the AGM. Therefore, it falls squarely under Proxy Solicitation & Information Statement (PSI).
2025-05-26 English
TERMS OF REFERENCE OF THE REMUNERATION AND APPRAISAL COMMITTEE UNDER THE BOARD OF THE COMPANY
Governance Information Classification · 92% confidence The document is the “Terms of Reference of the Remuneration and Appraisal Committee under the Board,” detailing the committee’s composition, duties, responsibilities, and procedures. This is a corporate governance charter setting out internal rules and structure rather than an actual remuneration disclosure or financial report. Therefore, it falls under Governance Information (CGR).
2025-05-26 English
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE UNDER THE BOARD OF THE COMPANY
Governance Information Classification · 85% confidence The document is not an announcement or a press release but the full Terms of Reference of the Nomination Committee, detailing the structure, duties, procedures, and corporate governance framework under the Board. This aligns with the definition of Governance Information (CGR) – reports that set out internal rules, board structures, committee charters, and governance practices.
2025-05-26 English
TERMS OF REFERENCE OF THE AUDIT COMMITTEE UNDER THE BOARD OF THE COMPANY
Governance Information Classification · 94% confidence The document is the “Terms of Reference of the Audit Committee” under the Board, detailing committee composition, duties, internal rules, and governance structure. It is not a financial report, earnings release, or meeting announcement but a governance framework document. This aligns with the definition of Governance Information (CGR).
2025-05-26 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.